The University of Birmingham in the UK has entered a licensing agreement with Covid-19 test provider Innova Medical Group for commercialising its new testing technology in the global markets.
The new reverse transcription-free exponential amplification reaction (RTF-EXPAR) technology provides detection in ten minutes.
It provides a quick, accurate, highly sensitive and simple test for detecting Covid-19, as revealed in detailed test assessments.
